spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BIO-Europe® 2017

BIO-Europe® 2017

6-8 November 2017
Messedamm 26 14055 Berlin Germany

BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings.

Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships.

The BIO-Europe 2017 partnering event is expected to draw over 3,800 industry attendees for three days of high level networking, representing upwards of 2,000 companies from over 60 countries.

Partnering as an overall business strategy has transformed drug development in bringing together innovators and visionaries with seasoned experts from every corner of the globe. Partnering at BIO-Europe is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners and pre-arrange private one-to-one meetings with dozens of company targets. The system—industry-specific, web-based and interactive—is uniquely suited for the needs of life science companies.

In addition to the program, two key elements at our partnering events are the presenting companies and the exhibition. At BIO-Europe, presenting companies are grouped into several tracks, including Biotech, Midsize Pharma, Next Generation, and Academic Innovators™. The high-exposure exhibition is the heart of the conference, and presents a prime opportunity to showcase products and services in a high-traffic location.

BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization (BIO).
For more information and online registration please visit our conference website at https://ebdgroup.knect365.com/bioeurope.

Producer:
EBD GmbH
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

Contact:
Catharine Moreno Finan
EBD Group GmbH
Munich Germany
T: +49 89 2388 756-25
cmoreno@ebdgroup.com

Speakers:
https://ebdgroup.knect365.com/bioeurope/speakers

Registration:
https://ebdgroup.knect365.com/bioeurope/registration-information

Program:
https://ebdgroup.knect365.com/bioeurope/agenda/1
phone +49 89 2388 756-25
email cmoreno@ebdgroup.com
web bit.ly/2F3PwIS
email RAI Amsterdam, Netherlands
 
Print this page
Send to a friend
   
spacer
Industry Events

BioTrinity 2018

23-25 April 2018, Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan Banner of T3_events_97 on Samedan Banner of BIO_Europe_Events_102 on Samedan

White Papers

Protein Therapeutics

Reading Scientific Services Ltd (RSSL)


More info >>


News and Press Releases

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement